Animal Health Industry

What Animal Health Industry does

The Animal Health Institute (AHI) is a Washington, D.C.-based trade association, founded in 1941, that represents the companies which develop and manufacture animal medicines in the United States. Its member roster spans major global animal health manufacturers and diagnostics suppliers, including Zoetis, Elanco, Merck Animal Health, Boehringer Ingelheim, IDEXX, Virbac, Dechra, Vetoquinol, Phibro, Ceva, Huvepharma, American Regent, Colorado Serum Company, Medgene Labs, and VMRD, collectively producing biologics (primarily vaccines), pharmaceuticals, and parasiticides used across companion and food-producing animals.

AHI's functional role is policy advocacy and regulatory coordination rather than product development or commercialization. It engages with FDA Center for Veterinary Medicine, USDA Center for Veterinary Biologics, and EPA on U.S. approvals, and with WOAH, Codex Alimentarius, VICH, and WTO on international standards and trade. It maintains a small operating team (1-10 employees) led by CEO Martha Scott Poindexter (appointed May 12, 2025) and a board chaired by Jamie Brannan of Zoetis. External touchpoints include flagship communications such as the "Cutest Pets on Capitol Hill" contest, periodic CEO thought-leadership, regulatory position statements, and published reports (e.g., HealthforAnimals' economic value analysis and Oxford Analytica's sustainability study). Recent activity centers on ADUFA VI reauthorization, the New World Screwworm response, pharmaceutical tariffs, and state-level policy on pet affordability and animal medicine compounding.

AHI is funded through membership dues paid by its member companies and does not sell products or services to end customers such as farmers, ranchers, veterinarians, or pet owners. Its underlying industry footprint is large — the global animal health market is estimated at $39.9 billion with the U.S. accounting for 32.6% (~$13.8 billion) in 2021 — but AHI's own revenue is determined by dues structure and is not publicly disclosed.

Name

Animal Health Industry

Legal name

Animal Health Institute

Website

https://ahi.org

Company type

Private

Founded year

1941

Operating status

Operating

Headcount range

1–10 employees

Short description

Washington, D.C. trade association representing U.S. animal health product manufacturers, advocating for science-based regulation and approval of biologics, pharmaceuticals, and parasiticides used in companion and food-producing animals.

Ownership category

akta.pro rank

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership Dues: The Animal Health Institute is funded through membership dues paid by its member companies, which include leading animal health pharmaceutical and biologics companies such as Zoetis, Elanco, Merck Animal Health, Boehringer Ingelheim, and others. As a trade association, AHI does not generate revenue from product sales.

Distribution channels1 record

Marketing channels5 records

Core offering

The Animal Health Institute (AHI) is a trade association that represents and advocates for companies developing and manufacturing animal medicines. It serves as the unified industry voice on U.S. federal regulatory and policy matters affecting biologics (vaccines), pharmaceuticals, and parasiticides used in companion animals and livestock. AHI is funded by membership dues from companies such as Zoetis, Elanco, Merck Animal Health, and Boehringer Ingelheim.

Product overview

The Animal Health Institute (AHI) is a trade association representing companies that develop and produce animal medicines. The industry offers three core product categories: Biologics (primarily vaccines that prevent diseases like rabies, parvovirus, and E. coli), Pharmaceuticals (addressing infections, diabetes, obesity, pain, cancer, and age-related diseases), and Parasiticides (flea and tick medications). Member companies include IDEXX (diagnostics), VMRD (diagnostic test kits), Medgene Labs (immunological products), Zoetis, Elanco, Merck Animal Health, Boehringer Ingelheim, and others. AHI also provides resources like the Flexible Signal Management Framework for pharmacovigilance. The industry serves nearly 10 billion companion and food-producing animals in the U.S.

Differentiator

Problem solved

Functional benefit

Products and services

• Biologics (Vaccines) Industry Representation Industry-wide category of vaccines and biological products developed and manufactured by AHI member companies, used to prevent diseases in companion animals (pets) and food-producing animals (livestock), reducing animal suffering and protecting public health through zoonotic disease prevention.
• Veterinary Pharmaceuticals Industry Representation Industry-wide category of veterinary pharmaceuticals produced by AHI member companies, treating infections, chronic conditions, and age-related diseases in animals, administered as pills, liquids, injections, powders, feed additives, and boluses.
• Parasiticides Industry Representation Industry-wide category of parasite control products developed by AHI member companies, protecting companion and food-producing animals against fleas, ticks, mites, and heartworms, preventing infestations that cause discomfort or diseases such as anemia and Lyme disease.
• AHI Trade Association Membership Membership-based trade association service providing animal health companies with unified representation before U.S. federal agencies (FDA, USDA, EPA), Congress, and international bodies (Codex Alimentarius, WOAH, VICH, WTO), plus regulatory coordination, policy advocacy, and industry-wide research publications.

Quantifiable outcome

• Global animal health market valued at $39.9 billion with U.S. representing 32.6% ($13.8 billion) as of 2021
• +1 more outcomes

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Nine partnerships are on record, tiered core and minor.

• HealthforAnimalscoreStrategic or Co-development PartnerGlobal representative body for animal health companies. AHI participates as a member organization representing U.S. animal health industry in international policy discussions and harmonization efforts.
• Codex Alimentarius CommissioncoreStrategic or Co-development PartnerJoint FAO/WHO body that establishes international food standards. AHI participates in Codex activities through HealthforAnimals membership, contributing to standards that affect animal medicine residues and trade.
• World Organization for Animal Health (WOAH)coreStrategic or Co-development PartnerInternational body setting standards for animal health and welfare. AHI engages with WOAH on global animal health policy, disease control frameworks, and antimicrobial resistance initiatives.
• International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Products (VICH)coreTechnology or IntegrationVICH harmonizes veterinary medicine registration requirements across EU, Japan, and U.S. AHI supports industry participation in VICH guideline development, enabling member companies to conduct studies acceptable across all three regions.
• U.S. Food and Drug Administration (FDA) Center for Veterinary MedicinecoreStrategic or Co-development PartnerFDA/CVM regulates animal pharmaceuticals. AHI works closely with CVM on drug approval processes, emergency use authorizations (e.g., New World Screwworm products), and regulatory Modernization initiatives including ADUFA VI discussions.
• U.S. Department of Agriculture (USDA) Center for Veterinary BiologicscoreStrategic or Co-development PartnerUSDA/CVB regulates animal biologics including vaccines. AHI engages with CVB on approval processes for veterinary biologics and response to foreign animal disease threats.
• U.S. Environmental Protection Agency (EPA)coreStrategic or Co-development PartnerEPA regulates flea and tick products as pesticides under FIFRA. AHI collaborates with EPA on parasiticides regulation and EPA/FDA coordination on animal health products.
• World Trade Organization (WTO)minorStrategic or Co-development PartnerWTO administers SPS and TBT agreements affecting international trade in animal health products. AHI engages on trade policy to ensure science-based standards for animal medicine trade.
• Reagan-Udall FoundationcoreStrategic or Co-development PartnerAHI supported the Reagan-Udall Foundation report 'Transforming Animal Health in the US for the 21st Century' which makes recommendations for modernizing the Center for Veterinary Medicine.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Regional players

• AnimalhealthEurope: European animal health industry trade association; the regional counterpart to AHI, advocating for animal pharma, vaccines, and parasiticide manufacturers at the EU level (EMA, EU Commission).

Broad incumbents

• HealthforAnimals: Global animal health industry association where AHI participates; functions as AHI's international counterpart on Codex, WOAH, and VICH harmonization, sharing membership and policy goals.
• American Veterinary Medical Association (AVMA): National professional association representing veterinarians; addresses overlapping animal health policy and regulatory issues, including drug use, antimicrobial stewardship, and practice economics that intersect with AHI's member-product advocacy.
• Biotechnology Innovation Organization (BIO): Large biotech trade association; AHI recently hired a Senior Director of State Affairs from BIO, signaling overlapping state-level lobbying playbooks and policy priorities around biologics, IP, and FDA regulation.

Direct peers

• Pet Food Institute: Trade association for US pet food manufacturers; the closest functional analog to AHI in the companion-animal side, working on FDA/CVM, USDA, and international standards that affect adjacent product categories.
• Generic Animal Drug Alliance: Trade association representing generic animal drug manufacturers; a niche peer that engages FDA CVM on similar issues (ADUFA, approval pathways) and competes for influence on overlapping legislative priorities.
• American Feed Industry Association (AFIA): Trade association representing the US animal feed industry; engages the same FDA Center for Veterinary Medicine and USDA on related regulatory and trade matters, making it a structural peer in DC animal-health advocacy.

Others

• National Milk Producers Federation: Dairy producer trade association with shared interests in livestock health, FDA CVM engagement, and antimicrobial stewardship policy, but representing farmers rather than animal health product companies.
• Consumer Healthcare Products Association (CHPA): Trade association for OTC consumer healthcare products; a structural analog in how it advocates for member manufacturers to FDA on regulatory modernization and consumer access issues.

Emerging players

• Animal Agricultural Alliance: Non-profit connecting food-animal supply chain stakeholders; advocates on animal welfare, antibiotic use, and sustainability — sharing overlapping One Health and food-system messaging with AHI.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/animalshealthy
• YouTubeyoutube.com/channel/UCDWdQqZp2uem_tj1yyvWV2g
• Facebookfacebook.com/animalshealthy
• LinkedInlinkedin.com/company/animal-health-institute
• Instagraminstagram.com/healthyanimals.healthypeople

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Animal Health Industry